La cadena de opciones muestra datos clave de las opciones de acciones de Planet Image Intl a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Planet Image Intl..

Planet Image Intl (NASDAQ:YIBO) Bolsa, Cadena de Opciones

Planet Image Intl

Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under three brands, TrueImage, CoolToner, and AZtech. The company operates in North America, Europe, and Other countries.

ACTU

ALVO

BACK

CSBR

EVGR

GLRE

HEPA

JDZG

JYNT

LUNG

PRTA

SRRK

UNTY

VREX

YIBO

ZKIN

IMAC Holdings sube más del 108% tras anunciar Ignite Proteomics. Conoce las acciones más destacadas en la negociación previa.

Acciones de IMAC Holdings se disparan un 108%; 20 acciones en movimiento en el premercado de EE.UU.

Planet Image International Limited - Class A Ordinary Shares

Planet Image International Ltd

Citigroup analyst George Choi maintains Las Vegas Sands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>) with a Buy and raises the price target from $64.5 to $67.

News

Price Target

Analyst Ratings

Citigroup Maintains Buy on Las Vegas Sands, Raises Price Target to $67

Maxim Group analyst Jason McCarthy maintains Alterity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) with a Buy and raises the price target from $8 to $12.

Alterity Therapeutics Limited - American Depositary Shares

ATHE

Maxim Group Maintains Buy on Alterity Therapeutics, Raises Price Target to $12

Earnings

HFBL

CORRECTION: Home Federal Bancorp Q2 EPS $0.33, Flat YoY

Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) has outperformed the market over the past 5 years by 18.24% on an annualized basis producing an average annual return of 31.2%. Currently, Cheniere Energy has a market capitalization of $51.65 billion. 
Buying $1000 In LNG: If an investor had bought $1000 of LNG stock 5 years ago, it would be worth $3,918.96 today based on a price of $230.20 for LNG at the time of writing.
<h3>Cheniere Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738277138_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Cheniere Energy 5 Years Ago Would Be Worth This Much Today

Shares of Common Stock are expected to begin trading on the New York Stock Exchange under the ticker symbol "INR." The offering is expected to close on February 3, 2025, subject to customary closing conditions.

IPOs

Infinity Natural Resources Prices Public Offering Of 13.25M Shares Of Class A Common Stock At $20.00 Per Share

Maxim Group analyst Allen Klee initiates coverage on Orangekloud Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) with a Buy rating and announces Price Target of $5.

Initiation

ORKT

Maxim Group Initiates Coverage On Orangekloud Technology with Buy Rating, Announces Price Target of $5

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares are falling in extended trading Thursday after the company <a href="https://www.benzinga.com/pressreleases/25/01/b43355741/walgreens-boots-alliance-suspends-quarterly-dividend-as-company-continues-disciplined-execution-ag">suspended its quarterly dividend</a>.
What Happened: After the market close on Thursday, Walgreens announced its board is suspending its cash dividend as management continues to evaluate its capital allocation policy as part of a longer-term turnaround strategy.
The suspended dividend is expected to help strengthen the company&#8217;s balance sheet by reducing debt over time and improving free cash flow.
&#8220;The company&#8217;s cash needs over the next several years, including with respect to litigation and debt refinancing, were important considerations as part of the decision to suspend the dividend,&#8221; the company said. 
&#8220;WBA leadership remains focused on successfully executing against its strategic priorities and maintaining financial discipline, which it believes will deliver sustained value creation over the long term.&#8221;
<h1 class="wp-block-heading">How To Buy WBA Stock</h1>
By now you're likely curious about how to participate in the market for Walgreens — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share. 
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading — either way it allows you to profit off of the share price decline.
WBA Price Action: <a href="http://benzinga.com/quote/wba">Walgreens shares</a> were down 7.77% after-hours, trading at $10.52 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43355688/apple-q1-earnings-revenue-beat-eps-beat-iphone-sales-slip-installed-base-climbs-to-all-time-high-our-best-quarter-ever">Apple Q1 Earnings: Revenue Beat, EPS Beat, iPhone Sales Slip, Installed Base Climbs To All-Time High — &#8216;Our Best Quarter Ever&#8217;</a></li>
</ul>
Photo: Courtesy of Walgreens Boots Alliance.

Dividends

After-Hours Center

Walgreens Boots Alliance Shares Slide As Board Suspends Dividend

For the quarter ended December 31, 2024, the company reported a net loss of $2.0 million, or $0.03 per diluted common share, compared to net income of $0.9 million, or $0.01 per diluted common share, for the quarter ended September 30, 2024, and a net loss of $5.8 million for the fourth quarter of 2023.&nbsp;

BRBS

Blue Ridge Bankshares Q4 EPS $(0.03), Says Regulatory Remediation Efforts On Track

Lake Street analyst Eric Martinuzzi maintains Extreme Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) with a Hold and raises the price target from $15 to $16.

EXTR

Lake Street Maintains Hold on Extreme Networks, Raises Price Target to $16

Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) reported its third-quarter financial results after Thursday's closing bell. Here's a look at the<a href="https://www.benzinga.com/pressreleases/25/01/b43352747/boot-barn-holdings-inc-announces-third-quarter-fiscal-year-2025-financial-results"> details from the report.&nbsp;</a>
The Details:&nbsp;Boot Barn reported earnings of $2.43 per share, beating the $2.29 estimate. Quarterly revenue came in at $608.17 million, beating the $607.01 million estimate.
Same-store sales increased 8.6% compared to the prior-year period, comprised of an increase of 8.2% in retail store same-store sales and an increase of 11.1% in e-commerce same-store sales. The company opened 13 new stores, bringing its total store count to 438 as of the quarter end.
Read Next: <a href="https://www.benzinga.com/general/travel/25/01/43343648/all-60-passengers-4-crew-members-onboard-american-airlines-jet-feared-dead-after-midair-collision-official-says">64 Killed In American Airlines Midair Collision Near D.C., Worst US Air Disaster Since 2001&nbsp;</a>
&#8220;I want to thank the entire Boot Barn team for their excellent execution and dedication during a busy holiday season, which resulted in strong third-quarter results and earnings per diluted share above the high end of our guidance range. The strength we saw in the business was once again driven by broad-based growth across all major merchandise categories, channels and geographies, resulting in a consolidated same-store sales increase of 8.6%,&#8221; said John Hazen, Interim CEO.
&#8220;We also grew total sales 16.9% compared to the prior-year period, driven in part by the 13 new stores we opened in the third quarter and the 39 new stores we have opened year-to-date through our third fiscal quarter,&#8221; Hazen added. 
Outlook:&nbsp;Boot Barn raised its fiscal 2025 GAAP EPS guidance from a range of&nbsp;$5.30 to $5.60 to a range of $5.81 to $5.90, versus the&nbsp;$5.76&nbsp;estimate, and raised its fiscal 2025 sales guidance from a range of $1.87 billion to $1.91 billion to&nbsp;a range of $1.91 billion to $1.92 billion, versus the $1.91 billion estimate. 
BOOT Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Boot Barn Holdings shares are down 6.60% after-hours at $163 on Thursday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43320124/microsoft-shares-slide-after-q2-results-cloud-revenue-misses-expectations-details">Microsoft Shares Slide After Q2 Results, Cloud Revenue Misses Expectations: Details</a>&nbsp;</li>
</ul>
Photo: Courtesy of Boot Barn Holdings, Inc.

Movers

BOOT

Boot Barn Stock Falls After Q3 Report: What To Know

Loop Capital analyst Alton Stump maintains Silgan Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLGN#NYSE">SLGN</a>) with a Buy and raises the price target from $70 to $75.

SLGN

Loop Capital Maintains Buy on Silgan Hldgs, Raises Price Target to $75

Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) has outperformed the market over the past 5 years by 7.19% on an annualized basis producing an average annual return of 20.15%. Currently, Coherent has a market capitalization of $14.03 billion. 
Buying $1000 In COHR: If an investor had bought $1000 of COHR stock 5 years ago, it would be worth $2,656.40 today based on a price of $90.71 for COHR at the time of writing.
<h3>Coherent's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738276219_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COHR

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Barclays analyst George Wang maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Overweight and raises the price target from $91 to $139.

Barclays Maintains Overweight on Celestica, Raises Price Target to $139

As AI develops, a shift in expectations for electricity demand is becoming more evident. The emergence of Chinese artificial intelligence company DeepSeek has led to uncertainty about future electricity consumption, impacting <a href="https://www.benzinga.com/topic/utilities">utility and power stocks. </a>
Investors in the traditional power and utilities sector are facing uncertainty after riding last year's wave of soaring demand projections. The rapid expansion of energy-intensive data centers—critical to AI and other tech innovations—had fueled a surge in power stocks. However, the question mark on this forecast has brought <a href="https://www.benzinga.com/etfs">power-focused ETFs</a> back into the limelight for the wrong reasons. Although experts believe this is most likely a temporary panic, here are 3 ETFs that may be less sensitive to short-term chaos:
Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) 
XLU provides exposure to major U.S. utility companies, including American Electric Power Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) and Southern Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SO#NYSE">SO</a>). The ETF is a popular choice for investors seeking stable returns and dividend income from regulated utilities, which are less sensitive to short-term market disruptions. The expense ratio is 0.09%.
Invesco S&amp;P 500 Equal Weight Utilities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSPU#NYSE">RSPU</a>)
Traditional utility ETFs are market-cap weighted. On the contrary, this ETF assigns equal weight to its holdings, which allows the investor to spread out risks. It includes companies involved in electricity production, transmission, and renewable energy, making it a potential hedge against volatility in the energy sector. The expense ratio is 0.4%.
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRID#NASDAQ">GRID</a>)
GRID focuses on companies engaged in smart grid technology, electrification infrastructure, and power transmission. As the U.S. accelerates its shift to renewable energy, investments in smart grids and electricity storage could benefit from long-term demand growth, regardless of AI-related fluctuations.
Also Read: <a href="https://www.benzinga.com/etfs/sector-etfs/25/01/43350500/deepseek-shakes-up-ai-stocks-3-healthcare-tech-etfs-offer-stability-innovation">DeepSeek Shakes Up AI Stocks: 3 Healthcare Tech ETFs Offer Stability, Innovation</a>
<h3 class="wp-block-heading">The AI Revolution and Its Impact on Power Demand</h3>
The DeepSeek issue challenges long-standing projections about electricity demand driven by AI data centers. DeepSeek&#8217;s AI model, reportedly uses &#8220;10 to 40 times less energy&#8221; than similar U.S. models, according to a <a href="https://www.eenews.net/articles/game-changer-what-deepseek-ai-means-for-electricity/">report </a>by E&amp;E News. 
Utilities and natural gas companies, which had been soaring on expectations of rising AI-driven electricity demand, suffered steep losses. According to Reuters, independent power provider Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) plunged by about 20%, Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) dropped 30%, and Talen Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLN#NASDAQ">TLN</a>) fell 22% after news of DeepSeek&#8217;s advancements hit.
While some experts believe this could reset expectations for power growth, others argue that broader electrification trends, including U.S. manufacturing expansion and cryptocurrency mining, will keep electricity demand high. 
&#8220;Overall electricity demand is still going to surge because other major drivers — particularly U.S. manufacturing and cryptocurrency — are not going to be affected by DeepSeek,&#8221; said Betsy Soehren Jones, managing director at West Monroe, as reported by E&amp;E News.
DeepSeek&#8217;s accomplishment could even cast doubt on nuclear power demand, which tech companies see as a key source of clean energy for AI development. Investors have expected high premiums for nuclear power, over $100/MWh, but new efficiency gains may change that, Jefferies said in a client note, <a href="https://www.argusmedia.com/en/news-and-insights/latest-market-news/2652323-deepseek-undermines-ai-power-demand-forecasts">according </a>to Argus Media. 
Lower AI data center power demand could also weaken support for next-generation small modular reactors (SMRs), backed by companies like Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43267966/deepseeks-low-cost-model-reshapes-ai-landscape-experts-predict-shift-to-application-layer">DeepSeek&#8217;s Low-Cost Model Reshapes AI Landscape: Experts Predict Shift To &#8216;Application Layer&#8217;</a>
<h3 class="wp-block-heading">What BofA Says About the Power and Utility Sector</h3>
A recent Bank of America (BofA) report suggests that the power and utility sector remains resilient despite the short-term market reaction to DeepSeek&#8217;s AI model. The report maintains a Buy rating on Constellation Energy with a revised price target of $366 and a Neutral rating on Vistra with a target of $183.
BofA analysts see the sell-off as an overreaction and expect data center demand to stay strong once the turbulence subsides.
The report describes DeepSeek as "more evolutionary than revolutionary" and that AI-driven data centers will continue to drive power consumption.
Additionally, BofA notes that supply and demand pressures in the energy market remain tight due to industrial expansion and electrification. The need for stable energy sources like nuclear power remains essential.
<h3 class="wp-block-heading">Will DeepSeek Really Change The Power Scenario?</h3>
While DeepSeek's AI model has introduced uncertainty in the short term, some analysts believe the sell-off in power stocks may be &#8220;short-sighted and short-lived,&#8221; as energy economist Ed Hirs noted, per a Reuters report. Even with more efficient AI models, demand for electricity is likely to rise due to continued digitalization and electrification.
All said, despite the sharp reaction in the market, broader trends in electrification and technology-driven growth suggest that electricity consumption will keep rising.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/01/43315374/ai-etfs-in-focus-as-alibaba-challenges-deepseek-with-new-model">AI ETFs In Focus As Alibaba Challenges DeepSeek With New Model</a></li>
</ul>
Photo: Sundry Photography/ Shutterstock.com

Sector ETFs

ETFs

GOOG

GOOGL

First Trust Nasdaq Clean Edge Smart Grid Infrastructure Index Fund

GRID

MSFT

Invesco S&P 500 Equal Weight Utilities ETF

RSPU

3 ETFs To Navigate Utility Stock Volatility As DeepSeek Challenges Power Demand Forecasts

Barclays analyst Saket Kalia maintains Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) with a Equal-Weight and raises the price target from $200 to $230.

CHKP

Barclays Maintains Equal-Weight on Check Point Software, Raises Price Target to $230

KOSS

Koss Q2 EPS $0.01 Up From $(0.03) YoY, Sales $3.56M Up From $3.36M YoY

Cipher Mining Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) shares are surging in Thursday&#8217;s after-hours session after the company announced a $50 million <a href="https://www.benzinga.com/pressreleases/25/01/g43352473/cipher-mining-announces-50-million-pipe-investment-from-softbank-group">PIPE investment from SoftBank</a>.
What Happened: Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) miner Cipher Mining has received a $50 million investment from SoftBank to support the company&#8217;s high-performance computing (HPC) data center development business. The PIPE investment also establishes SoftBank as a primary investor in Cipher.
&#8220;We are thrilled to welcome SoftBank as an important investor in Cipher. This investment comes at a pivotal moment in Cipher&#8217;s growth trajectory, as the Company continues to attract attention for its pipeline of sites and innovative solutions in industrial-scale data centers,&#8221; said Tyler Page, CEO of Cipher Mining.
&#8220;SoftBank&#8217;s focus on innovation in technology and AI development aligns with our vision to establish ourselves as a leader in HPC data center development.&#8221;
Cipher provided an operational update at the beginning of January, noting that it mined 234 Bitcoin in December and ended the month with an operating hashrate of 13.5 EH/s. 
Cipher focuses on the development and operation of industrial-scale data centers for Bitcoin mining and HPC hosting.&nbsp;
CIFR Price Action: <a href="http://benzinga.com/quote/cifr">Cipher Mining shares</a> were up 17.02% after hours, trading at $5.50 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
See Also: • <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43351667/bitcoin-ethereum-xrp-dogecoin-gain-momentum-ahead-of-weekend-as-bulls-eye-profitable-february">Bitcoin, Ethereum, XRP, Dogecoin Gain Momentum Ahead Of Weekend As Bulls Eye Profitable February</a>
Photo: Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Financing

$BTC

CIFR

Cipher Mining Stock Soars On PIPE Investment From SoftBank

Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) has outperformed the market over the past 10 years by 8.48% on an annualized basis producing an average annual return of 19.96%. Currently, Adobe has a market capitalization of $192.41 billion. 
Buying $100 In ADBE: If an investor had bought $100 of ADBE stock 10 years ago, it would be worth $620.13 today based on a price of $442.00 for ADBE at the time of writing.
<h3>Adobe's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738275401_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADBE

Here's How Much $100 Invested In Adobe 10 Years Ago Would Be Worth Today

RBKB

Rhinebeck Bancorp Q4 EPS $(0.25), Down From $0.09 YoY

Shore Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHBI#NASDAQ">SHBI</a>) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.35 by 14.29 percent. This is a 25 percent increase over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $44.01 million which beat the analyst consensus estimate of $43.55 million by 1.06 percent. This is a 5.99 percent increase over sales of $41.52 million the same period last year.

Earnings Beats

SHBI

Shore Bancshares Q4 2024 GAAP EPS $0.40 Beats $0.35 Estimate, Sales $44.01M Beat $43.55M Estimate

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Stocks near 52-week lows may feel like incredible bargains, but the savvy should recognize the risks.



Dumping these stocks is a strategic move, especially when they continue to trend downward, offering little to no upside potential ahead. When a stock continues reaching fresh lows, it&rsquo;s typically a sign of deep-seated issues. Some of these issues may include dwindling fundamentals or ongoing negative market trends.



Selling lackluster stocks near 52-week lows enables investors to redirect their funds to more promising opportunities, effectively enhancing their portfolios. This approach effectively sidesteps the pitfall of catching falling knives while reallocating resources to maximize long-term gains.



With that in mind, three downtrodden stocks have been major disappointments over the past 12 months. With their floundering underlying businesses and bleak futures, these stocks continue eroding shareholder value at a worrying pace while offering little to no upside ahead.



<h2>Planet Image (YIBO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/06/stocks-to-sell1600-4-300x169.png" alt="Hand pushing sell. Stocks to sell"><div>Source: chanpipat / Shutterstock.com</div></div>Planet Image (NASDAQ:<a href="https://investorplace.com/stock-quotes/yibo-stock-quote/">YIBO</a>) faces major headwinds in the toner cartridge space with its portfolio of brands like TrueImage and CoolToner. Over the past three years, sales have increased from $141.5 million in December 2020 to $150.2 million by December 2023. This lackluster growth reflects a secular decline, shifting consumer preferences towards digital solutions and eco-friendly products.



Despite operating multiple sales channels and catering to a global audience, the company&rsquo;s tepid growth is worrying. Its trajectory over the past few years indicates the drop in demand for traditional printing supplies. According to a report by Smithers, the industry plummeted nearly 15% between 2020 and 2022 and will continue losing value for the foreseeable future.



Unsurprisingly, the firm&rsquo;s recent public listing in late January was a massive flop, with the stock plummeting <a target="_blank" href="https://seekingalpha.com/symbol/YIBO/momentum/performance">by over 33% in the past six months</a>. Hence, given the market&rsquo;s lukewarm reception and questionable business viability, it&rsquo;s best to steer clear of YIBO stock.



<h2>Eventbrite (EB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/06/buy-hold-sell-stocks-keyboard-1600-300x169.jpg" alt='Keyboard with three keys reading "buy," "hold" and "sell" in green, yellow and red'><div>Source: shutterstock.com/Weitwinkel</div></div>Online event ticketing platform Eventbrite&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/eb-stock-quote/">EB</a>) <a href="https://seekingalpha.com/symbol/EB/momentum/performance">has lost more than 56%</a> of its value in the past year.



Despite the relatively encouraging top-line growth, Eventbrite&rsquo;s new creator fees have sparked significant backlash. Though the change boosted revenue per ticket, it also led to a massive drop in creator engagement and paid ticket volumes. Its first-quarter (Q1) revenue growth came in at $86.3 million, <a href="https://seekingalpha.com/news/4099203-eventbrite-gaap-eps-of-0_05-misses-0_01-revenue-of-86_25m-beats-0_99m">roughly 11% year-over-year (YOY)</a>, but was a massive deceleration from the 22% growth rate in the previous quarter.



More concerning was the 8% YOY drop in paid ticket volumes to 21 million, a sharper decline than the 4% drop in the last quarter. Moreover, Eventbrite&rsquo;s paid creator count dipped by 13,000 from the previous quarter to 170,000. Eventbrite also has to contend with stiff competition from major players such as StubHub and Ticketmaster, which significantly limits its upside potential.



<h2>Varex Imaging (VREX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/06/stocks-to-buy-stocks-to-sell-dice-1600-300x169.jpg" alt='Dice on top of stock chart reading "buy" and "sell"'><div>Source: shutterstock.com/SergeyP</div></div>Varex Imaging (NASDAQ:<a href="https://investorplace.com/stock-quotes/vrex-stock-quote/">VREX</a>), which produces X-ray imaging systems, continues struggling to establish a dominant position in its niche. It operates through the Medical and Industrial segments, which have failed to make an impression. This is shown by its dreary stock market performance, <a href="https://seekingalpha.com/symbol/VREX/momentum/performance" target="_blank">marked by a 37% drop</a> last year alone.



The Medical segment, typically the firm&rsquo;s revenue backbone, saw a distressing 13% YOY drop in sales during Q1. Moreover, its recently released Q2 results showed a worsening trend, with a 15% drop. These alarming numbers show how hospitals and medical facilities are delaying investments in new X-ray technology.



Additionally, VREX&rsquo;s Industrial segment, despite achieving a modest 6% growth in Q2, wasn&rsquo;t able to offset the firm&rsquo;s mounting losses in its medical division. <a target="_blank" href="https://seekingalpha.com/pr/19710856-varex-announces-financial-results-for-second-quarter-fiscal-year-2024?hasComeFromMpArticle=false&amp;source=section%253Amain_content%257Cbutton%253Abody_link%257Cfirst_level_url%253Anews">Company-wide sales plummeted by 10% YOY</a> to $206 million, indicating a worrying financial situation. Moreover, as the firm faces segment-specific and macroeconomic headwinds, its future appears remarkably uncertain, raising concerns over its sustainability.



On the&nbsp;date of publication, Muslim Farooque did not have (either&nbsp;directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Muslim Farooque is a keen investor and an optimist at heart. A life-long gamer and tech enthusiast, he has a particular affinity for analyzing technology stocks. Muslim holds a bachelor&rsquo;s of science degree in applied accounting from Oxford Brookes University.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/07/sell-alert-3-stocks-to-offload-near-52-week-lows/">Sell Alert: 3 Stocks to Offload Near 52-Week Lows</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Sell Alert: 3 Stocks to Offload Near 52-Week Lows

IPO Roundup: Lineage, OneStream Software, and more

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!



Moving stocks this morning are clinical trial updates, an acquisition deal and a public offering.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Planet Image (NASDAQ:<a href="https://investorplace.com/stock-quotes/yibo-stock-quote/">YIBO</a>) stock is rocketing more than 79% alongside heavy pre-market trading.</li>



<li>Lipella Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/lipo-stock-quote/">LIPO</a>) shares are soaring over 58% after <a href="https://www.stocktitan.net/news/LIPO/lipella-pharmaceuticals-initiates-phase-2a-trial-for-lp-310-in-oral-kdvluw7gmnv7.html">initiating a Phase 2a clinical trial</a>.</li>



<li>Cognition Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgtx-stock-quote/">CGTX</a>) stock is surging more than 44% with <a href="https://www.nasdaq.com/press-release/cognition-therapeutics-proof-concept-phase-2-shine-trial-demonstrates-consistent">positive Phase 2 study results</a>.</li>



<li>Tivic Health Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/tivc-stock-quote/">TIVC</a>) shares are gaining over 32% following a <a href="https://www.nasdaq.com/press-release/bestgrowthstockscom-issues-comprehensive-analysis-tivic-health-systems-potential">breakdown of its potential catalysts</a>.</li>



<li>Longeveron (NASDAQ:<a href="https://investorplace.com/stock-quotes/lgvn-stock-quote/">LGVN</a>) stock is increasing more than 22% with the release of <a href="https://www.nasdaq.com/press-release/longeveronr-presents-study-results-clear-mind-phase-2a-clinical-trial-lomecel-btm">Phase 2a study results</a>.</li>



<li>Pineapple Financial (NYSEMKT:<a href="https://investorplace.com/stock-quotes/papl-stock-quote/">PAPL</a>) shares are rising 22% without any clear news this morning.</li>



<li>Cepton (NASDAQ:<a href="https://investorplace.com/stock-quotes/cptn-stock-quote/">CPTN</a>) stock is climbing over 19% on <a href="https://www.stocktitan.net/news/CPTN/cepton-signs-definitive-agreement-to-be-acquired-by-7cwu0k4o8p93.html">an acquisition agreement</a>.</li>



<li>Ambipar Emergency (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ambi-stock-quote/">AMBI</a>) shares are jumping more than 18% this morning.</li>



<li>BurgerFi (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) stock is heading over 16% higher as it <a href="https://investorplace.com/2024/07/why-is-burgerfi-international-bfi-stock-up-71-today/">continues a recent rally</a>.</li>



<li>Vaccinex (NASDAQ:<a href="https://investorplace.com/stock-quotes/vcnx-stock-quote/">VCNX</a>) shares are up more than 15% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>vTv Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtvt-stock-quote/">VTVT</a>) stock is plummeting over 44% after announcing the Food and Drug Administration&nbsp;(FDA) <a href="https://www.nasdaq.com/press-release/vtv-therapeutics-announces-cadisegliatin-program-type-1-diabetes-placed-clinical-hold">placed a clinical hold</a> on one of its trials.</li>



<li>CERo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cero-stock-quote/">CERO</a>) shares are diving more than 33% despite a lack of news this morning.</li>



<li>Treasure Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/tgl-stock-quote/">TGL</a>) stock is tumbling over 25% on Monday morning.</li>



<li>LuxUrban Hotels (NASDAQ:<a href="https://investorplace.com/stock-quotes/luxh-stock-quote/">LUXH</a>) shares are taking a more than 17% beating after <a href="https://www.globenewswire.com/news-release/2024/07/27/2919920/0/en/LuxUrban-Hotels-Announces-Pricing-of-Public-Offering-of-Securities.html">pricing a public offering</a>.</li>



<li>Invo Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/invo-stock-quote/">INVO</a>) stock is dropping over 11% without any clear news to report.</li>



<li>Phio Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/phio-stock-quote/">PHIO</a>) shares are sliding more than 11% this morning.</li>



<li>Notable Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/ntbl-stock-quote/">NTBL</a>) stock is decreasing over 10% on Monday morning.</li>



<li>Regencell Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/rgc-stock-quote/">RGC</a>) shares are falling more than 9% after a Friday rally.</li>



<li>Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) stock is slipping over 9% after jumping Friday <a href="https://finance.yahoo.com/news/carbon-revolution-supplies-carbon-fiber-011000695.html">on a wheels deal</a>.</li>



<li>Nuwellis (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuwe-stock-quote/">NUWE</a>) shares close out our pre-market stock movers down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-29th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Planet Image&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/yibo-stock-quote/">YIBO</a>) stock is heading higher on Monday alongside heavy pre-market trading of the ancillary printer components company&rsquo;s shares this morning.



That has more than 3.9 million shares traded as of this writing. To put that in perspective, the company&rsquo;s daily average trading volume is only about 8,000 shares. Its float is also low <a href="https://finance.yahoo.com/quote/YIBO/key-statistics/">at 1.78 million units</a>.



Investors will note that the YIBO stock movement this morning comes without any clear news. That includes a lack of press releases or filings with the Securities and Exchange Commission (SEC). There&rsquo;s also no analyst coverage that would cause this morning&rsquo;s rally.



One thing that investors will want to keep in mind is that YIBO is a penny stock. This comes from its low daily average trading volume and prior closing price of $2.92.



<h2>What That Means for YIBO Stock</h2>



Being a penny stock comes with certain disadvantages. That includes attracting the attention of speculative or retail and day traders. This can cause volatility in these shares.



Considering the heavy trading of YIBO stock today and the lack of news, this is likely behind its gains. However, the stock may not remain up for long on this type of rally. Traders will want to consider that before taking a stake in Planet Image.



YIBO stock is up 53.4% as of Monday morning.



InvestorsPlace is home to all of the most recent stock market stories traders need to know about on Monday!



We have the hottest market happenings worth reading about today! That includes the biggest pre-market stock movers this morning and other news. You can read up on all of that at the links below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-29th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>



<li><a href="https://investorplace.com/2024/07/will-the-july-jobs-report-trigger-a-stock-market-crash-on-aug-2/">Will the July Jobs Report Trigger a Stock Market Crash on Aug. 2?</a></li>



<li><a href="https://investorplace.com/2024/07/raymond-james-just-issued-a-major-warning-on-nvidia-nvda-stock/">Raymond James Just Issued a Major Warning on Nvidia (NVDA) Stock</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-planet-image-yibo-stock-up-53-today/">Why Is Planet Image (YIBO) Stock Up 53% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Planet Image (YIBO) Stock Up 53% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Lipella Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lipo-stock-quote/">LIPO</a>) stock is flying higher on Monday after the company presented investors <a href="https://www.globenewswire.com/news-release/2024/07/29/2920081/0/en/Lipella-Pharmaceuticals-Initiates-Phase-2a-Trial-for-LP-310-in-Oral-Lichen-Planus-Enrolls-First-Patients.html">with an update</a> on its Phase 2a clinical trial evaluating LP-310.



This is the company&rsquo;s drug candidate for the treatment of Oral Lichen Planus (<a href="https://investorplace.com/stock-quotes/olp-stock-quote/">OLP</a>). That&rsquo;s a chronic inflammatory condition that affects more than 6 million Americans and lacks a Food and Drug Administration (FDA)-approved treatment.



Lipella Pharmaceuticals notes that the clinical trial is now underway. That comes after it recruited patients across multiple site locations. It&rsquo;s also screening more patients to take part in the study.



Lipella Pharmaceuticals CEO Dr. Jonathan Kaufman said the following about the news.




&ldquo;We are very pleased with the rapid pace of site activation, and the enrollment of our initial patients marks a pivotal milestone for both the company and the patient community suffering from this debilitating condition. This achievement reinforces our mission to redefine treatment paradigms for Oral Lichen Planus.&rdquo;




<h2>LIPO Stock Movement Today</h2>



With today&rsquo;s news comes heavy trading of LIPO shares. That has more than 41 million units changing hands as of this writing. To put that in perspective, its daily average trading volume is about 46,000 shares.



LIPO stock is up 145.8% as of Monday morning.



We have all of the hottest stock market news traders need to know about on Monday! Among that is what has shares of Planet Image&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/yibo-stock-quote/">YIBO</a>) stock up, the biggest pre-market stock movers this morning and more. All of this info is ready to go at the links below!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-planet-image-yibo-stock-up-53-today/">Why Is Planet Image (YIBO) Stock Up 53% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-29th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>



<li><a href="https://investorplace.com/2024/07/will-the-july-jobs-report-trigger-a-stock-market-crash-on-aug-2/">Will the July Jobs Report Trigger a Stock Market Crash on Aug. 2?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-lipella-pharmaceuticals-lipo-stock-up-149-today/">Why Is Lipella Pharmaceuticals (LIPO) Stock Up 149% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Lipella Pharmaceuticals (LIPO) Stock Up 149% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
VTv Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vtvt-stock-quote/">VTVT</a>) stock is falling hard on Monday after the Food and Drug Administration (FDA) <a href="https://www.nasdaq.com/press-release/vtv-therapeutics-announces-cadisegliatin-program-type-1-diabetes-placed-clinical-hold">placed a clinical hold</a> on its cadisegliatin clinical program.



According to a news release from the company, that hold includes its TT1 Phase 3 trial in type 1 diabetes. The hold was put in place following a chromatographic signal in a human absorption, distribution, metabolism, and excretion (ADME) study of cadisegliatin.



This clinical hold requires vTv Therapeutics to conduct an in vitro study before it can resume its trial. That will have it seeking to characterize the signal to satisfy the FDA&rsquo;s requirements.



VTv Therapeutics chairman, president and CEO Paul Sekhri said the following about the clinical hold.




&ldquo;Patient safety is our top priority, and we appreciate the thoroughness of the FDA to better understand this signal. We are working diligently with the Agency to resolve the clinical hold and resume enrollment as quickly as possible.&rdquo;




<h2>How This Affects VTVT Stock Today</h2>



With this news comes strong trading of VTVT shares on Monday. That has more than 10,000 shares changing hands. While that may not seem like much, the company&rsquo;s daily average trading volume is just above it at roughly 15,000 shares.



VTVT stock is down 45.7% as of Monday morning.



Investors will want to keep reading for more of the most recent stock market stories today!



We have all of the hottest market new ready to go on Monday! A few examples include why shares of Lipella Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lipo-stock-quote/">LIPO</a>) and Planet Image&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/yibo-stock-quote/">YIBO</a>) stock are up, as well as the biggest pre-market stock movers this morning. All of this info is ready to go at the links below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-lipella-pharmaceuticals-lipo-stock-up-149-today/">Why Is Lipella Pharmaceuticals (LIPO) Stock Up 149% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-planet-image-yibo-stock-up-53-today/">Why Is Planet Image (YIBO) Stock Up 53% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-29th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-vtv-therapeutics-vtvt-stock-down-46-today/">Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
LuxUrban Hotels&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/luxh-stock-quote/">LUXH</a>) stock is taking a beating on Monday after the home leasing and rental company <a href="https://www.globenewswire.com/news-release/2024/07/27/2919920/0/en/LuxUrban-Hotels-Announces-Pricing-of-Public-Offering-of-Securities.html">priced a public offering</a> of its shares.



LuxUrban Hotels priced 11,573,333 shares of LUXH stock at 15 cents each in this public offering. It also granted the underwriters of the offering a 30-day option to acquire another 15% of shares sold in this offering.



LuxUrban Hotels is expecting gross proceeds of $1,736,000 or $1,996,400 from this offering depending on if rights are exercised. The company says it intends to use these funds for working capital and other general corporate purposes.



<h2>What This Means for LUXH Stock</h2>



A public offering increases the total number of outstanding shares on the market. That means it dilutes the stakes of current investors in LUXH. This is one of the reasons why LuxUrban Hotels stock is dropping today.



On top of that is the company&rsquo;s stock price of 15 cents per share in the offering. That&rsquo;s a decent discount over its prior closing price of 19 cents per share. It makes sense the stock would fall with this offering devaluing LUXH shares.



LUXH stock is down 12.2% as of Monday morning.



There are plenty more stock market stories traders will want to read about below!



We have all of the hottest stock market news investors need to know about on Monday! That includes everything happening with shares of vTv Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vtvt-stock-quote/">VTVT</a>) stock, Lipella Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lipo-stock-quote/">LIPO</a>) stock and Planet Image&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/yibo-stock-quote/">YIBO</a>) stock today. All of this news is ready to go at the links below!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-vtv-therapeutics-vtvt-stock-down-46-today/">Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-lipella-pharmaceuticals-lipo-stock-up-149-today/">Why Is Lipella Pharmaceuticals (LIPO) Stock Up 149% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-planet-image-yibo-stock-up-53-today/">Why Is Planet Image (YIBO) Stock Up 53% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-luxurban-hotels-luxh-stock-down-12-today/">Why Is LuxUrban Hotels (LUXH) Stock Down 12% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is LuxUrban Hotels (LUXH) Stock Down 12% Today?

Planet Image International GAAP EPS of $0.09, revenue of $77.26M

Planet Image International Limited Class A (YIBO) has released an update. Planet Image International Limited reported a modest revenue increase of ...

Planet Image Posts Revenue Growth Amid Market Challenges

An update from Planet Image International Limited Class A ( ($YIBO) ) is now available. Planet Image International Limited has had its Form 6-K rev...

Comments

Planet Image Intl

Planet Image Intl (YIBO) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL